Invesco Biotechnology & Genome ETF
PBE
#2116
ETF Rang
€0.22 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
72,72 €
Aktienkurs
0.05%
Veränderung (1 Tag)
29.99%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 2. Juni 2026Anzahl der Bestände: 32

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
6.76%
Illumina IncILMN126737
5.84%
United Therapeutics CorpUTHR32934
4.95%
Biogen IncBIIB79805
4.67%
Incyte CorpINCY154149
4.42%
Gilead Sciences IncGILD105529
4.41%
Amgen IncAMGN40671
4.39%
Alnylam Pharmaceuticals IncALNY46766
4.00%
Regeneron Pharmaceuticals IncREGN20194
3.74%
Veracyte IncVCYT238048
3.61%
Catalyst Pharmaceuticals IncCPRX351223
3.35%
TG Therapeutics IncTGTX278500
3.33%
Royalty Pharma PLCRPRX187161
3.30%
Neurocrine Biosciences IncNBIX64905
3.20%
CareDx IncCDNA441375
3.10%
Arrowhead Pharmaceuticals IncARWR133449
3.06%
BioCryst Pharmaceuticals IncBCRX1116443
3.00%
Exelixis IncEXEL188247
2.98%
Protagonist Therapeutics IncPTGX97250
2.76%
PTC Therapeutics IncPTCT123197
2.63%
Halozyme Therapeutics IncHALO120745
2.51%
Vericel CorpVCEL222141
2.51%
Repligen CorpRGEN63103
2.41%
Bio-Techne CorpTECH147484
2.38%
Ionis Pharmaceuticals IncIONS99400
2.38%
BioMarin Pharmaceutical IncBMRN135690
2.37%
ACADIA Pharmaceuticals IncACAD345522
2.28%
Theravance Biopharma IncTBPH445794
2.05%
QIAGEN NVQGEN175188.3786
1.88%
Collegium Pharmaceutical IncCOLL188078
1.73%
MannKind CorpMNKD1533639
0.03%
Invesco Government & Agency PortfolioAGPXX93749.38
-0.02%
CASH & EQUIVALENTSUSD-49392.06